XGN Financials

Exagen Inc - Financial statements & key metrics

Stock Price

$7.12

Market Cap

$154.12M

P/E Ratio

-8.6

EPS

$-0.83

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$55.64M

Gross Profit

-

Operating Income

-

Net Income

$-15.12M

EPS (Diluted)

$-0.83

Balance Sheet Highlights

Total Assets

$44.69M

Total Liabilities

$35.15M

Shareholders Equity

-

Cash & Equivalents

$22.04M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-13.28M

CapEx

-

Free Cash Flow

-

Profitability Metrics

Net Margin

-27.2%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is XGN revenue?

XGN's most recent quarterly revenue was $55.64M. Annual revenue can be calculated by summing the four most recent quarters.

Is XGN profitable?

XGN reported a loss of $15.12M in the most recent quarter. The net profit margin is -27.2%.

What is XGN market cap?

XGN has a market capitalization of $154.12M, making it a small-cap stock.

Does XGN have debt?

View XGN's balance sheet for debt information.

What is XGN cash flow?

Cash flow data is available in the full financial statements.

Explore Categories